That means it would be worthwhile for them to spend $500m to get it approved.
one could argue that w/ m-enox approval Teva may decide not to make the investment required... certainly now there is less incentive to do so. Agree w/ Mpower that $ are not all that is needed to make the equation work here (@ least in the short run).
The creation of a thousand forests is in one acorn.